The $6.5 million project is a collaboration among Gannon, AHN Saint Vincent and First Ascent Biomedical, a Miami-based ...
A small early trial from Vanderbilt hints that an investigational cardiovascular drug could cut cancer’s spread.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results